Clinical Trial

Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.
Trial Details
NCT Number NCT07084688
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Cradiovascular-kidney-liver-metabolic (CKLM) Syndrome, Cardiovascular-kidney-metabolic Syndrome
Enrollment 1,500 participants
Start Date 2025-07-14
Primary Completion 2040-07 (estimated)
Study Completion 2040-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-24